Navigation Links
MRIGlobal Engages Industry Expert in Expansion of Molecular Diagnostic Division
Date:9/9/2013

KANSAS CITY, Mo., Sept. 9, 2013 /PRNewswire-USNewswire/ -- MRIGlobal today announced that it is working with Mary E. Holland as part of its continuing expansion of its Molecular Diagnostics Division, which helps commercial diagnostics developers get their products to market faster.

Holland brings years of experience in creating and expanding market segments in Clinical Molecular Diagnostics, with a focus on the development and marketing of core product lines for clinical reference laboratories and diagnostic product manufacturers. She will work closely with Maureen Thornton, Head of Global Business Development for MRIGlobal Molecular Diagnostics, and Meeta Patnaik, M.D.

Holland has served in multiple leadership roles, playing a key role in solidifying brand and product awareness as well as driving profits for multiple companies that went public or to a merger/acquisition by Fortune 500 companies.

She most recently served as Vice President of Sales and Marketing with Madison, Wisconsin-based EraGen Biosciences, now part of Luminex; prior to that she played an integral role in launching Third Wave Technologies. As an entrepreneur, she co-founded Oncogenetics Inc., a comprehensive cancer diagnostic reference laboratory.

"Mary Holland brings diverse and highly relevant experience to the MRIGlobal Molecular Diagnostics Team," said Michael Cassler, Ph.D., Director of MRIGlobal Diagnostics.  "She will help increase our service offering to a broader customer base and further our continued expansion into the commercial diagnostics sector, a priority for our business.  We are both excited and fortunate to have someone of Mary's caliber working for us as a key member of our team." 

About MRIGlobal

MRIGlobal Molecular Diagnostics is a division of MRIGlobal, established in 1944 as Midwest Research Institute. MRIGlobal is based in Kansas City, Mo., operates in nine states and Washington, D.C. MRIGlobal employs more than 500 and manages 2,600-plus workers through management and operations programs with government clients.

MRIGlobal's Diagnostics Division provides assay development for menu expansion in in vitro and molecular diagnostics, validation and clinical testing, sample access and reference material, and platform engineering and integration. MRIGlobal operates a Clinical Laboratory Improvement Amendments (CLIA)-laboratory accredited by the College of American Pathologists. MRIGlobal is ISO 9001 certified and employs current Good Manufacturing Practices and Good Laboratory Practices, and maintains Biosafety Level 3 laboratories.

For more information, visit www.mriglobal.org/diagnostics.


'/>"/>
SOURCE MRIGlobal
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MRIGlobal, DHMRI Align in Strategic Collaboration
2. NineSigma Engages AtriCure in the Ohio Third Frontier Open Innovation Incentive Program
3. New Resource Provides Herb Industry With Sources of Quality Specifications
4. Garage Start-ups Now Possible in Life Sciences Industry
5. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
6. Internal and External Communications Excellence for the Pharmaceutical Industry: Increasing Organizational Effectiveness
7. Free Job Training: 55 Grants Available to Retrain Workers for Biofuels Industry
8. Hybrid Fuels, Inc. Appoints Industry Expert as New CEO
9. Prolongs Large Scale Manufacturing of Sickle Cell Product to be Headed by Industry Veteran
10. Ohios Bioscience Industry Effort Paying Off With Increase in Graduates and Accolades for the State
11. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Oxford Gene Technology ... Palette an anpassbaren SureSeq™ NGS-Panels mit dem Start ... ein schnelles und kostengünstiges Studium der Varianten bei ... Erkennung von Einzel-Nukleotid-Variationen (Single Nucleotide Variation, SNV) und ... Panel und ermöglicht eine individuelle Anpassung durch die ...
(Date:12/8/2016)... ... December 08, 2016 , ... Microbial genomics leader, uBiome, joins ... one of just six company finalists in the Health & Medicine category. Over ... nominated as finalists in this year’s awards include Google, SpaceX, Oculus, and SolarCity. ...
(Date:12/8/2016)... , Dec. 8, 2016 Savannah ... remediation technologies and selected NewTechBio,s NT-MAX Lake ... microbial based beneficial bacteria, in conjunction with Hexa ... correct deficiencies with National Pollutant Discharge Elimination System ... has experienced a steady history of elevated pH ...
(Date:12/7/2016)... ... December 07, 2016 , ... A new study published ... of previously treated, advanced pancreatic cancer, liquid biopsies are not yet an adequate ... timing of blood sampling may improve the value of a blood-based test.” The ...
Breaking Biology Technology:
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
(Date:6/27/2016)... 2016 Research and Markets has announced the ... report to their offering. The ... to grow at a CAGR of 12.28% during the period ... an in-depth market analysis with inputs from industry experts. The report ... years. The report also includes a discussion of the key vendors ...
(Date:6/21/2016)... British Columbia , June 21, 2016 /PRNewswire/ ... appointed to the new role of principal product ... been named the director of customer development. Both ... NuData,s chief technical officer. The moves reflect NuData,s ... teams in response to high customer demand and ...
Breaking Biology News(10 mins):